Literature DB >> 18234473

Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways.

Patricia Gangoiti1, María H Granado, Shih Wei Wang, Jennifer Y Kong, Urs P Steinbrecher, Antonio Gómez-Muñoz.   

Abstract

Ceramide 1-phosphate (C1P) was first shown to be mitogenic for fibroblasts, but the mechanisms whereby it stimulated cell proliferation have remained largely unknown. Here we demonstrate that C1P stimulates DNA synthesis and cell division in murine bone marrow-derived macrophages. C1P caused rapid phosphorylation of protein kinase B (PKB, also known as Akt), a downstream target of phosphatidylinositol 3-kinase (PI3-K). Selective inhibition of PI3-K blocked both DNA synthesis and cell growth. C1P induced phosphorylation of GSK-3beta, which is a major target of PKB, and this effect was also abolished by inhibition of PI3-K. In addition, C1P upregulated the expression of cyclin D1 and c-Myc, two major targets of GSK-3beta, which are important regulators of cell proliferation. C1P stimulated the activity of NF-kappaB, and inhibitors of this transcription factor completely blocked macrophage proliferation. Lastly, C1P induced phosphorylation of the mitogen activated protein kinases (MAPK) extracellularly regulated kinases 1 and 2 (ERK1/2), and c-Jun N-terminal kinase (JNK). Inhibition of ERK1/2 and JNK also blocked C1P-induced macrophage proliferation. It can be concluded that C1P stimulates macrophage proliferation through activation of the PI3-K/PKB, ERK and JNK pathways, and that GSK-3beta, c-Myc, cyclin D1, and NF-kappaB are important downstream effectors in this action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18234473     DOI: 10.1016/j.cellsig.2007.12.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  50 in total

Review 1.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 2.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

3.  JNK is necessary for oligodendrocyte precursor cell proliferation induced by the conditioned medium from B104 neuroblastoma cells.

Authors:  Jing-Xing Zhang; Yi-Fan Feng; Qi Qi; Lin Shen; Rui Wang; Jian-Sheng Zhou; He-Zuo Lü; Jian-Guo Hu
Journal:  J Mol Neurosci       Date:  2014-02       Impact factor: 3.444

Review 4.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 5.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

6.  Caged ceramide 1-phosphate analogues: synthesis and properties.

Authors:  Ravi S Lankalapalli; Alberto Ouro; Lide Arana; Antonio Gómez-Muñoz; Robert Bittman
Journal:  J Org Chem       Date:  2009-11-20       Impact factor: 4.354

Review 7.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

8.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26

9.  Ceramide 1-phosphate stimulates glucose uptake in macrophages.

Authors:  Alberto Ouro; Lide Arana; Patricia Gangoiti; Io-Guané Rivera; Marta Ordoñez; Miguel Trueba; Ravi S Lankalapalli; Robert Bittman; Antonio Gomez-Muñoz
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

10.  The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.

Authors:  Dorit Avni; Amir Philosoph; Michael M Meijler; Tsaffrir Zor
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.